A phase 1/2 double-blind, placebo-controlled study of SAGE-217 in an insomnia model-MedSci.cn

A phase 1/2 double-blind, placebo-controlled study of SAGE-217 in an insomnia model

Bullock, A; Gunduz-Bruce, H; Zammit, G; Sankoh, A; Li, H; Qin, M; Silber, C; Kanes, S; Jonas, J; Doherty, J